Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Kevin J Westbrook und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
Objectives
To investigate the genomic diversity and β-lactam susceptibilities of Enterococcus faecalis collected from patients with infective endocarditis (IE).
Methods
We collected 60 contemporary E. faecalis isolates from definite or probable IE cases identified between 2018 and 2021 at the University of Pittsburgh Medical Center. We used whole-genome sequencing to study bacterial genomic diversity and employed antibiotic checkerboard assays and a one-compartment pharmacokinetic–pharmacodynamic (PK/PD) model to investigate bacterial susceptibility to ampicillin and ceftriaxone both alone and in combination.
Results
Genetically diverse E. faecalis were collected, however, isolates belonging to two STs, ST6 and ST179, were collected from 21/60 (35%) IE patients. All ST6 isolates encoded a previously described mutation upstream of penicillin-binding protein 4 (pbp4) that is associated with pbp4 overexpression. ST6 isolates had higher ceftriaxone MICs and higher fractional inhibitory concentration index values for ampicillin and ceftriaxone (AC) compared to other isolates, suggesting diminished in vitro AC synergy against this lineage. Introduction of the pbp4 upstream mutation found among ST6 isolates caused increased ceftriaxone resistance in a laboratory E. faecalis isolate. PK/PD testing showed that a representative ST6 isolate exhibited attenuated efficacy of AC combination therapy at humanized antibiotic exposures.
Conclusions
We find evidence for diminished in vitro AC activity among a subset of E. faecalis IE isolates with increased pbp4 expression. These findings suggest that alternate antibiotic combinations against diverse contemporary E. faecalis IE isolates should be evaluated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Tsinghua University School of Medicine, Beijing, China.
- Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX, USA.
- Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
- Department of Medicine, Weill Cornell Medical College, New York, NewYork, USA.
- Center for Evolutionary Biology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
ORCID-Profile: William R Miller, Yohei Doi, Ryan K Shields, Daria Van Tyne
Förderung
- NIH HHS
- NIAID NIH HHS
- Wellcome Trust
Zitieren
APA
Westbrook, K. J., Chilambi, G. S., Stellfox, M. E., Nordstrom, H. R., Li, Y., Iovleva, A., Shah, N. H., Jones, C. E., Kline, E. G., Squires, K. M., Miller, W. R., Tran, T. T., Arias, C. A., Doi, Y., Shields, R. K., & Van Tyne, D. (2024). Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae032
Vancouver
Westbrook KJ, Chilambi GS, Stellfox ME, Nordstrom HR, Li Y, Iovleva A, et al. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae032
BibTeX
@article{Westbrook2024,
author = {Westbrook, Kevin J and Chilambi, Gayatri Shankar and Stellfox, Madison E and Nordstrom, Hayley R and Li, Yanhong and Iovleva, Alina and Shah, Niyati H and Jones, Chelsea E and Kline, Ellen G and Squires, Kevin M and Miller, William R and Tran, Truc T and Arias, Cesar A and Doi, Yohei and Shields, Ryan K and Van Tyne, Daria},
title = {Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae032}
}
EUVIMED